Yantai Dongcheng Biochemicals: Announcement regarding the subsidiary company obtaining a drug clinical trial approval notification.
Yantai Dongcheng Biochemicals: Announcement on the Progress of Providing Guarantees for Subsidiaries and Their Subsidiaries.
Yantai Dongcheng Biochemicals: 002675 Dongcheng Pharmaceutical Investor Relations Management Information 20240508
Yantai Dongcheng Biochemicals: Notice on subsidiary companies obtaining approval notices for drug clinical trials
Yantai Dongcheng Biochemicals: 2023 Annual Audit Report
Yantai Dongcheng Biochemicals: Announcement of Supervisory Board Resolutions
Yantai Dongcheng Biochemicals: 2023 Independent Director Debriefing Report (Zhao Dayong)
Yantai Dongcheng Biochemicals: Announcement on 2024 Company and Subsidiaries Applying for Credit Lines from Banks
Yantai Dongcheng Biochemicals: Opinions of Minsheng Securities Co., Ltd. on the deposit and use of funds raised by Yantai Dongcheng Pharmaceutical Group Co., Ltd. in 2023
Yantai Dongcheng Biochemicals: Report on the evaluation of the performance of accounting firms
Yantai Dongcheng Biochemicals: Special instructions on the use of funds raised in the year
Yantai Dongcheng Biochemicals: Announcement on holding an online performance briefing for the 2023 Annual Report
Yantai Dongcheng Biochemicals: Independent Director's Annual Debriefing Report
Yantai Dongcheng Biochemicals: Announcement on confirmation of daily related transactions in 2023
Yantai Dongcheng Biochemicals: Annual Verification Report on the Use of Raised Funds
Yantai Dongcheng Biochemicals: Audit opinions of the board of supervisors on matters related to the company
Yantai Dongcheng Biochemicals: Announcement of Board Resolutions
Yantai Dongcheng Biochemicals: Notice on changes in accounting policies
Yantai Dongcheng Biochemicals: Internal Control Audit Report
Yantai Dongcheng Biochemicals: Annual special audit report on the expenditure of related parties' funds
No Data